 | Up a level |
Boughton, C K; Bally, Lia; Hartnell, S; Wilinska, M; Coll, A P; Evans, M; Stettler, Christoph; Hovorka, R (2019). Closed-loop insulin delivery in end-of-life care: a case report. Diabetic medicine, 36(12), pp. 1711-1714. Wiley 10.1111/dme.13974
Bally, L; Thabit, H; Ruan, Y; Mader, J K; Kojzar, H; Dellweg, S; Benesch, C; Hartnell, S; Leelarathna, L; Wilinska, M E; Evans, M L; Arnolds, S; Pieber, T R; Hovorka, R (2018). Bolusing frequency and amount impacts glucose control during hybrid closed-loop. Diabetic medicine, 35(3), pp. 347-351. Wiley 10.1111/dme.13436
Carroll, P V; Christ, E R; Umpleby, A M; Gowrie, I; Jackson, N; Bowes, S B; Hovorka, R; Croos, P; Sönksen, P H; Russell-Jones, D L (2000). IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes, 49(5), pp. 789-96. Alexandria, Va.: American Diabetes Association 10.2337/diabetes.49.5.789
